Woods D A, Loganathan K
Great Western Hospital, Swindon SN3 6BB, UK.
University of Bristol, Senate House, Tyndall Avenue, Bristol BS8 1TH, UK.
Bone Joint J. 2017 Jun;99-B(6):812-817. doi: 10.1302/0301-620X.99B6.BJJ-2016-1133.R1.
Manipulation under anaesthetic (MUA) is a recognised form of treatment for patients with a frozen shoulder. However, not all patients benefit. Some have persistent or recurrent symptoms. There are no clear recommendations in the literature on the optimal management of recurrent frozen shoulder after a MUA. We aimed to address this issue in this study.
We analysed a prospectively collected, single-surgeon, consecutive series of patients who underwent MUA for frozen shoulder between January 1999 and December 2015. The Oxford Shoulder Scores (OSS) and range of movement were the outcome measures.
A total of 730 patients (792 shoulders) underwent MUA during the study period. A further MUA was undertaken in 141 shoulders (17.8%), for which we had complete data for 126. The mean improvement in OSS for all patients undergoing MUA was 16 (26 to 42), and the mean post-operative OSS in those requiring a further MUA was 14 (28 to 42; -test, no difference between mean improvements, p = 0.57). Improvement was seen after a further MUA, regardless both of the outcome of the initial MUA, and of the time of recurrence. Patients with type-1 diabetes mellitus were at a 38% increased risk of requiring a further MUA, compared with the 18% increased risk of the group as a whole (p < 0.0001).
Patients with a poor outcome or recurrent symptoms of a frozen shoulder after a MUA should be offered a further MUA with the expectation of a good outcome and a low complication rate. Cite this article: 2017;99-B:812-17.
麻醉下手法松解(MUA)是公认的肩周炎患者治疗方式。然而,并非所有患者都能从中获益。部分患者症状持续或复发。目前文献中对于MUA后复发性肩周炎的最佳管理尚无明确建议。本研究旨在解决这一问题。
我们分析了1999年1月至2015年12月间由同一位外科医生连续收治的、接受MUA治疗肩周炎的前瞻性收集病例系列。牛津肩部评分(OSS)和活动范围作为疗效指标。
研究期间共有730例患者(792肩)接受了MUA。其中141肩(17.8%)接受了再次MUA,我们获得了126肩的完整数据。所有接受MUA患者的OSS平均改善值为16(从26至42),而需要再次MUA患者的术后OSS平均值为14(从28至42;t检验,平均改善值之间无差异,p = 0.57)。无论初次MUA的结果以及复发时间如何,再次MUA后均可见改善。与总体人群18%的增加风险相比,1型糖尿病患者需要再次MUA的风险增加38%(p < 0.0001)。
MUA后肩周炎预后不佳或症状复发的患者应接受再次MUA,有望获得良好疗效且并发症发生率低。引用本文:2017;99-B:812 - 17。